nOligos (nLife)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamenOligos (nLife)
Drug Alias Nameneuronal specific oligonucleotides (nLife)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesnLife Therapeutics SL
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesnLife Therapeutics SL
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A